GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
221 hedge funds and large institutions have $2.44B invested in Genomic Health, Inc. in 2019 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 48 increasing their positions, 84 reducing their positions, and 53 closing their positions.
Holders
221
Holders Change
+6
Holders Change %
+2.79%
% of All Funds
4.85%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
59
Increased
48
Reduced
84
Closed
53
Calls
$1.5M
Puts
$3.13M
Net Calls
-$1.63M
Net Calls Change
-$1.87M
Top Buyers
| 1 |
1
BlackRock
New York
|
$276M |
| 2 |
AAM
2
Alpine Associates Management
Palm Beach,
Florida
|
$53.5M |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$40.3M |
| 4 |
MF
4
Magnetar Financial
Evanston,
Illinois
|
$32.8M |
| 5 |
IA
5
IndexIQ Advisors
New York
|
$29.9M |
